ClinicalTrials.Veeva

Menu

Clinical, Molecular and Metabolic Characteristics of Parkinson's Disease (PD) Patients With Parkin Mutation

G

Groupe Hospitalier Pitie-Salpetriere

Status

Unknown

Conditions

Parkinson's Disease

Treatments

Device: positron emission tomography

Study type

Interventional

Funder types

Other

Identifiers

NCT00169364
P011104

Details and patient eligibility

About

Parkinson's disease is a frequent neurodegenerative disorder. Genetic forms of the disease have been recently identified. The monogenic form due to parkin mutation is responsible for many familial cases and sporadic forms. However, the relationship between the mutation and the genotype of patients is not fully established. The aim of this study is to compare clinical, metabolic and neuropsychological characteristics obtained in patients with parkin mutation with those of patients without parkin mutation.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Juvenile Parkinson's disease (< 45 years)
  • Parkin mutation
  • Normal brain magnetic resonance imaging (MRI)

Exclusion criteria

  • Contraindication to brain MRI
  • Women without effective contraception

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

Alexis Brice, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems